Q3 2022 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good day, and welcome to the Inovio Third Quarter 2022 Results Conference Call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Mr. Thomas Hong. Please go ahead, sir.
Thank you. Good afternoon, and thank you for joining the Inovio Third Quarter 2022 Financial Results Conference Call. Joining me on today's call are Dr. Jacqui Shea, President and CEO; Mr. Peter Kies, Chief Financial Officer; and Dr. Michael Sumner, Chief Medical Officer. We also have other members of Inovio's leadership here with us today, who will be part of our Q&A session.
Today's call will review our corporate and financial information for the quarter ended September 30, 2022 as well as provide an update on our efforts to develop our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.
During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |